Lantheus Holdings (LNTH) Free Cash Flow Growth (1y) (2015 - 2026)
Lantheus Holdings (LNTH) Free Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 134.35% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 17.21% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -37.45% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 58.76% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 97.24% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 43.69% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 35.56% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn | 13.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.55% |
| Mar 31, 2026 | 19.85% |
| Dec 31, 2025 | -74.57% |
| Sep 30, 2025 | -21.93% |
| Jun 30, 2025 | 61.22% |
| Mar 31, 2025 | -15.51% |
| Dec 31, 2024 | 55.05% |
| Sep 30, 2024 | 40.33% |
| Jun 30, 2024 | 231.99% |
| Mar 31, 2024 | 20.32% |
| Dec 31, 2023 | 73.16% |
| Sep 30, 2023 | -9.73% |
| Jun 30, 2023 | -164.01% |
| Mar 31, 2023 | 1,314.43% |
| Dec 31, 2022 | 4,874.56% |
| Sep 30, 2022 | 2,229.52% |
| Jun 30, 2022 | 163.84% |
| Mar 31, 2022 | -27.95% |
| Dec 31, 2021 | -81.11% |
| Sep 30, 2021 | -10.31% |